Troponins Touted as ‘Ally’ in COVID-19 Triage

Posted April 18, 2020 Alan Reid

Troponins Touted as ‘Ally’ in COVID-19 Triage.

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047008

⟵COVID-19 Statement form UK NEQAS and UK NEQAS Cardiac Markers

HEART Editorial: High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action⟶

Upcoming Events

Distribution 280 – Final Date for Input of Results

September 24
Distribution 280 – Report Issued (week beginning)

September 27
Distribution 281 – Distribution Opens

October 4

View All Events

Get In Touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF

+44 (0)141 440 2888

info@ukneqas-cm.org.uk

About UKNEQAS

Since 1969 the United Kingdom National External Quality Assessment Service (UK NEQAS) has been providing a comprehensive world-wide service that enables laboratories to fulfil quality goals and facilitate optimal patient care. UK NEQAS now comprises a network of 390 schemes operating from 26 centres based at major hospitals, research institutions and universities throughout the UK.

NHS Greater Glasgow & Clyde, operating UK NEQAS Cardiac Markers, is a UKAS accredited proficiency testing provider (No:8560)(BS EN ISO/IEC 17043:2010). We are a non-profit centre working within NHS Greater Glasgow and Clyde to improve cardiac biomarker investigations in the clinical laboratory sector for the benefit of patients.

Get in touch

Level 1 (Room B/046), Laboratory Medicine & Facilities Management Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF

+44 (0)141 440 2888

info@ukneqas-cm.org.uk